(Q39404898)

11 September 2017

title

Efficacy and safety of eletriptan 20 mg, 40 mg and 80 mg in Japanese migraineurs (English)

1 reference

11 September 2017

1 reference

Eletriptan Steering Committee in Japan

series ordinal

1

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

11 September 2017

1 reference

11 September 2017

volume

22

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

416-423

1 reference

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

Prevalence of migraine in Japan: a nationwide survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

Determination of eletriptan in plasma and saliva using automated sequential trace enrichment of dialysate and high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

On closed testing procedures with special reference to ordered analysis of variance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

Sumatriptan. An updated review of its use in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

Rizatriptan: a review of its efficacy in the management of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

Zolmitriptan: a review of its use in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2002.00372.X

10.1046/J.1468-2982.2002.00372.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference